News from the FDA/CDC

CDC identifies probable culprit in vaping lung injuries


 

Recommendations

CDC recommends that people should not buy any type of e-cigarette, or vaping, products, particularly those containing THC, off the street. They should also refrain from modifying or adding any substances to e-cigarette, or vaping, products that are not intended by the manufacturer, including products purchased through retail establishments.

Dr. Layden concluded, “we are in a better place today than we were a few weeks ago in terms of having one very strong culprit of concern based on the lung fluid testing,” but since the specific substances causing lung injury are not yet known, the only way to assure that individuals are not at risk while the investigation continues is to consider refraining from use of all vaping products.

For more information and resources visit For the Public, For Healthcare Providers, and For Health Departments pages, as well as the CDC’s Publications and Resources page.

Pages

Recommended Reading

Race mismatch may affect survival in lung transplant setting
Journal of Clinical Outcomes Management
FDA approves Trikafta for treatment of cystic fibrosis
Journal of Clinical Outcomes Management
New test edges closer to rapid, accurate ID of active TB
Journal of Clinical Outcomes Management
ACIP recommends two options for pertussis vaccination
Journal of Clinical Outcomes Management
ACIP plans flu review for older adults
Journal of Clinical Outcomes Management
ACIP approves child and adolescent vaccination schedule for 2020
Journal of Clinical Outcomes Management
THC use reported in majority of vaping-related illnesses
Journal of Clinical Outcomes Management
Measles infection linked to impaired ‘immune memory’
Journal of Clinical Outcomes Management
U.S. deaths from preventable causes occur more often in rural areas
Journal of Clinical Outcomes Management
Tide beginning to turn on vaccine hesitancy
Journal of Clinical Outcomes Management